UBS Group’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.3M | Buy |
3,518,671
+414,541
| +13% | +$2.98M | ﹤0.01% | 1673 |
|
|
2025
Q1 | $18.6M | Buy |
3,104,130
+2,890,196
| +1,351% | +$17.3M | ﹤0.01% | 1843 |
|
|
2024
Q4 | $1.67M | Buy |
213,934
+98,439
| +85% | +$768K | ﹤0.01% | 3867 |
|
|
2024
Q3 | $1.25M | Sell |
115,495
-11,044
| -9% | -$119K | ﹤0.01% | 3409 |
|
|
2024
Q2 | $1.07M | Sell |
126,539
-304,466
| -71% | -$2.57M | ﹤0.01% | 3350 |
|
|
2024
Q1 | $2.9M | Buy |
431,005
+203,598
| +90% | +$1.37M | ﹤0.01% | 2663 |
|
|
2023
Q4 | $1.34M | Buy |
227,407
+148,333
| +188% | +$872K | ﹤0.01% | 3208 |
|
|
2023
Q3 | $771K | Sell |
79,074
-3,401
| -4% | -$33.2K | ﹤0.01% | 3294 |
|
|
2023
Q2 | $977K | Sell |
82,475
-10,475
| -11% | -$124K | ﹤0.01% | 3334 |
|
|
2023
Q1 | $1M | Sell |
92,950
-124,134
| -57% | -$1.34M | ﹤0.01% | 3172 |
|
|
2022
Q4 | $2.51M | Buy |
217,084
+184,452
| +565% | +$2.13M | ﹤0.01% | 2379 |
|
|
2022
Q3 | $487K | Buy |
32,632
+32,083
| +5,844% | +$479K | ﹤0.01% | 3395 |
|
|
2022
Q2 | $5K | Buy |
549
+130
| +31% | +$1.18K | ﹤0.01% | 7810 |
|
|
2022
Q1 | $3K | Buy |
+419
| New | +$3K | ﹤0.01% | 8372 |
|
|
2021
Q4 | – | Sell |
-258
| Closed | -$2K | – | 9137 |
|
|
2021
Q3 | $2K | Buy |
+258
| New | +$2K | ﹤0.01% | 7781 |
|
|
2020
Q4 | – | Sell |
-340
| Closed | -$1K | – | 7376 |
|
|
2020
Q3 | $1K | Buy |
+340
| New | +$1K | ﹤0.01% | 6880 |
|
|
2020
Q2 | – | Sell |
-8,475
| Closed | -$4K | – | 7081 |
|
|
2020
Q1 | $4K | Buy |
+8,475
| New | +$4K | ﹤0.01% | 6454 |
|
|
2018
Q4 | – | Sell |
-8,436
| Closed | -$87K | – | 7081 |
|
|
2018
Q3 | $87K | Buy |
8,436
+5,116
| +154% | +$52.8K | ﹤0.01% | 4829 |
|
|
2018
Q2 | $48K | Buy |
+3,320
| New | +$48K | ﹤0.01% | 5088 |
|